Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,810
Closed -$297K 133
2025
Q1
$297K Hold
4,810
0.12% 116
2024
Q4
$347K Sell
4,810
-38,000
-89% -$2.97M 0.12% 112
2024
Q3
$3.49M Sell
42,810
-5,450
-11% -$436K 1.2% 34
2024
Q2
$3.58M Sell
48,260
-2,570
-5% -$193K 1.3% 23
2024
Q1
$3.96M Buy
50,830
+19,054
+60% +$1.42M 1.27% 27
2023
Q4
$2.27M Sell
31,776
-2,300
-7% -$160K 0.73% 61
2023
Q3
$2.36M Sell
34,076
-23,463
-41% -$1.77M 0.81% 51
2023
Q2
$4.66M Buy
57,539
+2,083
+4% +$170K 1.48% 14
2023
Q1
$4.48M Sell
55,456
-6,300
-10% -$507K 1.44% 16
2022
Q4
$4.62M Sell
61,756
-25,250
-29% -$1.8M 1.31% 23
2022
Q3
$5.61M Sell
87,006
-6,000
-6% -$416K 1.6% 13
2022
Q2
$6.45M Sell
93,006
-10,000
-10% -$742K 1.78% 12
2022
Q1
$7.91M Sell
103,006
-2,067
-2% -$149K 1.49% 16
2021
Q4
$8.04M Sell
105,073
-6,620
-6% -$487K 1.43% 20
2021
Q3
$8.24M Buy
111,693
+11,000
+11% +$825K 1.18% 22
2021
Q2
$6.72M Buy
100,693
+25,000
+33% +$1.67M 0.93% 30
2021
Q1
$5.63M Buy
+75,693
New +$5.75M 0.81% 38

Other funds holding HOLX

Formula Growth's HOLX Position: Q2 2025 in Review

Formula Growth sold out of Hologic (HOLX) in Q2 2025, closing a stake of 4,810 shares — an estimated $297K sold.

Formula Growth first reported a position in HOLX in Q1 2021 and held it in 17 quarters. The position peaked at $8.24M in Q3 2021. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Formula Growth reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Formula Growth sold 4,810 Hologic shares in Q2 2025, an estimated $297K.
  • Formula Growth first reported a position in Hologic in Q1 2021 and held it in 17 quarters.
  • Formula Growth's Hologic position peaked at $8.24M in Q3 2021.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Formula Growth's 13F filing for Q2 2025, filed 13 Aug 2025.